Aleksander Krag
Krag, Aleksander
VIAF ID: 3354154741641653110008 (Personal)
Permalink: http://viaf.org/viaf/3354154741641653110008
Preferred Forms
- 100 0 _ ‡a Aleksander Krag
-
- 100 1 _ ‡a Krag, Aleksander
- 100 1 _ ‡a Krag, Aleksander
- 100 1 _ ‡a Krag, Aleksander
4xx's: Alternate Name Forms (2)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review | |
Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. | |
Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention | |
Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosis | |
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. | |
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt | |
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide | |
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension. | |
Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium Colitis | |
Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients | |
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy. | |
Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury | |
Fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis. | |
Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis | |
The heart and the liver. | |
High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. | |
High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis | |
How to achieve a smooth transition from fellowship to faculty | |
The human gut-liver-axis in health and disease, 2019: | |
Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system | |
[In Process Citation] | |
Internal dysregulation of the renin system in patients with stable liver cirrhosis. | |
Is liver stiffness equal to liver fibrosis? | |
Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis? | |
Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters | |
Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes | |
Lack of consensus for usage of β-blockers in end-stage liver disease | |
Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses | |
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation | |
Managing excessive alcohol consumption at a population level: The earlier the better. | |
Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients | |
Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. | |
No impact of fish oil supplements on bleeding risk: a systematic review | |
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis | |
Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials | |
Noninvasive proteomic biomarkers for alcohol-related liver disease | |
Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients. | |
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis | |
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension. | |
Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases. | |
Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis | |
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. | |
Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study | |
Prescribing of acid suppressive therapy: interactions between hospital and primary care | |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension | |
Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial | |
The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5 | |
Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia | |
Reliability Criteria for Liver Stiffness Measurements with Real-Time 2D Shear Wave Elastography in Different Clinical Scenarios of Chronic Liver Disease | |
Reply | |
Research report: do general practitioners tell their patients about side effects to common treatments? | |
Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. | |
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial. | |
Ruling out esophageal varices in NAFLD cirrhosis: Can we do without endoscopy? | |
Safety and efficacy of Profermin® to induce remission in ulcerative colitis. | |
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy | |
Screening studies of transient elastography and FibroTest in the general population - Authors' reply. | |
Serological Assessment of the Quality of Wound Healing Processes in Crohn's Disease | |
Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. | |
Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients | |
Serum neutrophil gelatinase-associated lipocalin - a sensitive novel marker of renal impairment in liver cirrhosis? | |
Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders | |
Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. | |
Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension | |
Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications | |
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. | |
Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy. | |
Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers. | |
Terlipressin and hyponatraemia: the cause or the treatment? | |
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome | |
Terlipressin vs. octreotide in bleeding esophageal varices. | |
Tidlig opsporing af alkoholrelateret leversygdom | |
Time to Reconsider Listing Criteria for Alcohol-Associated Liver Disease? | |
To block, or not to block in advanced cirrhosis and ascites: that is the question | |
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis | |
Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury | |
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis. | |
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia | |
Treatment of acute variceal bleeding | |
Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease | |
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure | |
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease | |
প্রত্যুত্তর |